According to Genmab's latest financial reports the company has a price-to-book ratio of 4.03871.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 2.62 | -40.99% |
2023-12-31 | 4.44 | -37.56% |
2022-12-31 | 7.12 | -8.18% |
2021-12-31 | 7.75 | -8.21% |
2020-12-31 | 8.44 | 23.34% |
2019-12-31 | 6.84 | -16.19% |
2018-12-31 | 8.17 | -18.08% |
2017-12-31 | 9.97 | -32.1% |
2016-12-31 | 14.7 | -6.24% |
2015-12-31 | 15.7 | 55.14% |
2014-12-31 | 10.1 | -39.32% |
2013-12-31 | 16.6 | 62.9% |
2012-12-31 | 10.2 | |
2011-12-31 | N/A | -100% |
2010-12-31 | 3.15 | |
2009-12-31 | N/A |